The involvement of 5-HT3 and 5-HT4 receptors in two models of gastrointestinal transit in mice
- 5 July 2002
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 326 (3), 163-166
- https://doi.org/10.1016/s0304-3940(02)00251-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A Randomized Controlled Clinical Trial of the Serotonin Type 3 Receptor Antagonist Alosetron in Women With Diarrhea-Predominant Irritable Bowel SyndromeArchives of Internal Medicine, 2001
- Role of Opioid Ligands in the Irritable Bowel SyndromeCanadian Journal of Gastroenterology, 1999
- 5‐HTP induced diarrhea as a carcinoid syndrome model in mice?Fundamental & Clinical Pharmacology, 1996
- RS 39604: a potent, selective and orally active 5‐HT4 receptor antagonistBritish Journal of Pharmacology, 1995
- Effect of a 5HT3‐antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 1993
- 5-HT3 Receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndromeJournal of Medicinal Chemistry, 1993
- Short-circuit current responses to 5-hydroxytryptamine in human ileal mucosa are mediated by a 5-HT4 receptorEuropean Journal of Pharmacology, 1993
- The Irritable Bowel Syndrome: Mechanisms and a Practical Approach to ManagementAnnals of Internal Medicine, 1992
- A new method for measuring auricular inflammation in the mouseJournal of Pharmacological Methods, 1991
- Croton oil pleurisy induces pulmonary hyperreactivityPharmacological Research Communications, 1988